Coloplast A/S
CLPBF
$57.64
$0.360.62%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.33B | 4.22B | 4.13B | 4.06B | 4.00B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.33B | 4.22B | 4.13B | 4.06B | 4.00B |
| Cost of Revenue | 1.41B | 1.36B | 1.32B | 1.32B | 1.30B |
| Gross Profit | 2.92B | 2.87B | 2.81B | 2.75B | 2.70B |
| SG&A Expenses | 1.62B | 1.59B | 1.55B | 1.52B | 1.49B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -21.11M | -21.52M | -21.30M | -6.12M | -3.89M |
| Total Operating Expenses | 3.17B | 3.07B | 2.99B | 2.96B | 2.92B |
| Operating Income | 1.17B | 1.16B | 1.14B | 1.10B | 1.08B |
| Income Before Tax | 535.86M | 937.20M | 910.86M | 903.49M | 934.69M |
| Income Tax Expenses | 207.70M | 331.29M | 373.49M | 309.56M | 279.39M |
| Earnings from Continuing Operations | 328.16 | 605.91 | 537.37 | 593.93 | 655.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 328.16M | 605.91M | 537.37M | 593.93M | 655.30M |
| EBIT | 1.17B | 1.16B | 1.14B | 1.10B | 1.08B |
| EBITDA | 1.82B | 1.35B | 1.32B | 1.28B | 1.25B |
| EPS Basic | 1.46 | 2.69 | 2.39 | 2.64 | 2.91 |
| Normalized Basic EPS | 2.94 | 2.79 | 2.73 | 2.57 | 2.63 |
| EPS Diluted | 1.46 | 2.69 | 2.38 | 2.64 | 2.91 |
| Normalized Diluted EPS | 2.94 | 2.79 | 2.73 | 2.57 | 2.63 |
| Average Basic Shares Outstanding | 901.00M | 901.20M | 901.20M | 900.80M | 900.20M |
| Average Diluted Shares Outstanding | 901.09M | 901.29M | 901.29M | 900.89M | 900.49M |
| Dividend Per Share | 3.59 | 3.52 | 3.52 | 3.21 | 3.21 |
| Payout Ratio | 244.93% | 132.66% | 133.79% | 121.05% | 108.32% |